BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Meng LF, Zhang W, Wang JY, Zhang YG, Zhang P, Liao LM, Lv JW, Ling Q, Wei ZQ, Zhong T, Xu ZH, Wen W, Li JY, Luo DY. Clinical outcomes of sacral neuromodulation in non-neurogenic, non-obstructive dysuria: A 5-year retrospective, multicentre study in China. World J Clin Cases 2020; 8(12): 2494-2501 [PMID: 32607326 DOI: 10.12998/wjcc.v8.i12.2494]
URL: https://www.wjgnet.com/2307-8960/full/v8/i12/2494.htm
Number Citing Articles
1
Mai Ahmed Banakhar. Sacral neuromodulation implanted patients: Patient concerns during the COVID-19 pandemic and practical modificationsTherapeutic Advances in Urology 2021; 13: 175628722199813 doi: 10.1177/1756287221998135
2
Rahmi Onur, Sona Tayebi, Hanieh Salehi‐Pourmehr, Elham Jahantabi, Marie‐Aimee Perrouin‐Verbe, Changiz Naseri, Sakineh Hajebrahimi, Hashim Hashim. Sacral neuromodulation in patients with detrusor underactivity: Is biological sex an indicator?Neurourology and Urodynamics 2022; 41(3): 847 doi: 10.1002/nau.24893
3
Ifrah Masood, Qi Chen, Jiayi Li, Zhihui Xu, Xiaoqian Ying, Yiming Wang, Guoqing Chen, Limin Liao. Sacral Neuromodulation in Patients With Neurogenic Lower Urinary Tract Dysfunction: A Multicenter Retrospective Study From ChinaNeuromodulation: Technology at the Neural Interface 2021; 24(7): 1278 doi: 10.1111/ner.13383